Melanoma Coverage from Every Angle

Drs. Coit and Shoushtari on Melanoma: The Team Approach to Managing Toxicities of Checkpoint Inhibitors

Posted: Friday, May 25, 2018

Daniel G. Coit, MD, and Alexander N. Shoushtari, MD, both of Memorial Sloan Kettering Cancer Center, talk about how community practitioners can assemble a group of specialists with expertise in managing toxicities of immune checkpoint inhibitors.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.